2023 Preview

A new year, a fresh outlook for beaten-up biotech companies? There are some hopes that conditions will improve during 2023, though few are expecting a dramatic recovery. View the webinar for expert views on the year ahead, and a look at the challenges and opportunities that will present themselves.

Amy Brown and Edwin Elmhirst from Evaluate Vantage, discuss what the coming year is likely to bring.